Bio-Rad Laboratories, Inc. (BIO-B) Dividend Yield, History & Forecast

Bio-Rad Laboratories, Inc. (BIO-B) is a Medical - Devices company in the Healthcare sector listed on the New York Stock Exchange. The trailing twelve-month payout ratio is 19.7%; the market capitalization is approximately $7.57B.

Loading quote...

Frequently Asked Questions about Bio-Rad Laboratories, Inc. (BIO-B)

Is Bio-Rad Laboratories, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Bio-Rad Laboratories, Inc. in?
Bio-Rad Laboratories, Inc. (BIO-B) operates in the Healthcare sector, specifically the Medical - Devices industry.
What is Bio-Rad Laboratories, Inc.'s dividend payout ratio?
Bio-Rad Laboratories, Inc. (BIO-B)'s trailing twelve-month dividend payout ratio is 19.7%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.